Genetic Testing
Scientists have said that a standard gene testing for patients who have been diagnosed with metastatic gastrointestinal stromal tumors (GIST) will be more cost-effective. They have said that the financial estimate will support the widespread adoption of this approach. A study of genetic tests and modified first-line cure shows that using genetic testing to match the treatment of KIT differences to the imatinib dose is a less expensive way as compared to empirical imatinib. Experts have said that genetic test helps doctors to give chemotherapy in a tumor-specific way. In this case, those patients who do not get any relief from imatinib are given the alternative cure. This study has been published in JAMA Network Open.
The author of the study, David Geffen has said that genetic test is cheap as it avoids futile treatment and low rates of disease growth. He has made a Markov model to match the efficiency of the targeted gene test and modified first-line therapy with imatinib therapy in patients with GIST. The key factor for assessing the cost efficiency of the gene test has been quality of life years (QALY). The cost-efficiency of gene testing is defined by the incremental cost-effectiveness ratio. An incremental cost-effectiveness ratio, which is less than $100000, is considered cost-effective. As per the study, a therapy directed by the gene test is linked with an increase of 0.10 QALYs, at $9513 as compared to empirical imatinib. It leads to an incremental cost-effectiveness ratio of $92100. However, experts have said that the findings are sensitive to the costs of targeted gene tests, drugs, and health utility model efforts.
Experts have said that 70 percent of times, a targeted gene test is quite cost-efficient. The results of the study show that therapy directed by targeted gene tests can be cheaper if it gets hold of more share in the market, as of now imatinib therapy has a larger market share. Experts have advised patients with newly detected GIST that they should go for genetic testing before the start of first-line chemotherapy. They have said that this way patients who do not get any relief from imatinib, can be given a better treatment for their lumps. Experts have said that there is a need for further studies to substantiate the findings.
Introduction The global Epoxy Composites Market is poised for robust growth, expected to expand from…
Introduction The global Hydrotreating Catalyst Market is experiencing significant growth and is projected to reach…
Introduction The global Phosphates Market is poised for steady growth, with its size expected to…
Introduction The global Redispersible Polymer Powder Market is projected to experience significant growth over the…
Introduction The global Market for Copper Clad Laminates (CCL) is poised for substantial growth, with…
Introduction The global Cosmetic Emulsifier Market is anticipated to expand significantly from USD 712 Million…
Introduction The global Water Clarifiers Market is projected to expand from USD 7.4 Billion in…
Introduction The global Particle Board Market, valued at USD 24.2 Billion in 2023, is anticipated…
Introduction According to Market.us, The global Trenchless Pipe Rehabilitation Market is poised for significant expansion,…
Introduction The global Geohazard Market, focused on assessing and mitigating geological risks such as earthquakes,…
Introduction The Global Non-Alcoholic Tequila Market is poised for significant growth, anticipated to expand from…
Introduction The global Butyl Methacrylate (BMA) Market, with its broad scope of application across key…
Introduction The global Bio-Butanol Market is set for significant expansion, with projections suggesting growth from…
Introduction The global Hybrid Composites Market is poised for robust growth, projected to expand from…
Introduction The Polyhydroxyalkanoate (PHA) Market is poised for substantial growth over the next decade, driven…
Introduction The PMMA Recycling Market is poised for significant expansion from 2023 to 2033, with…
Introduction The Global Reflective Polarizing Films Market is poised for substantial growth, projected to expand…
Introduction The Mexico Biostimulants Market, valued at USD 48 Million in 2023, is projected to…
Introduction The global Nylon Market, valued at USD 34.3 Billion in 2023, is poised for…
Introduction The global Acrylic Acid Market, valued at approximately USD 13.5 Billion in 2023, is…